You are here

Standard Textile Product Earns ‘Innovative Technology’ Designation from Novation

Recognizes development of new solutions that benefit healthcare industry

CINCINNATI — Standard Textile’s DermaTherapy® line of textiles and apparel, designed to address the critical and costly issue of skin breakdown due to moisture, friction and sheer, has received an Innovative Technology designation from Novation, the company reports.

Novation is a healthcare services company that serves the more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association and Provista.

The designation was based on reviews of DermaTherapy technology, extensive published clinical trials and clinician testimonials by hospital experts who attended Novation’s Innovative Technology Expo in November, according to Standard Textile.

“Novation is committed to providing the members we serve with leading-edge technologies that deliver new clinical and operational benefits from what is currently available in the market today,” says Debbie Archer, director of procurement and leader of the Innovative Technology program for suppliers. “After reviewing Standard Textile and DermaTherapy at our annual Innovative Expo, the hospital experts who attended agreed the product offers unique and incremental benefit over other products available on the market today and recommended it for the Innovative Technology designation.”

The company says that DermaTherapy is evidence-based, patented, silk-like bedding and patient apparel. Formal clinical studies assessing the performance of DermaTherapy products have included more than 2,000 patients, according to the company.

“We know that the way to address rising healthcare costs is through innovation, and Standard Textile remains committed to bringing our customers bold technology that helps people live a healthier, more gratifying life,” says Norman Frankel, executive vice president of sales, Standard Textile.

standardtextile novation logos merge web

Have a question or comment? E-mail our editor Matt Poe at [email protected].